SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
13,106,546
Share change
-1,701,844
Total reported value
$114,169,970
Put/Call ratio
132%
Price per share
$8.71
Number of holders
82
Value change
-$14,578,469
Number of buys
41
Number of sells
40

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2015

As of 31 Dec 2015 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 13,106,546 shares of stock of the company.
Largest 10 holders included Wildcat Capital Management, LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, FRANKLIN RESOURCES INC, and NORTHERN TRUST CORP.
This table shows 82 institutional shareholders of the security as of 31 Dec 2015.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.